Cor Vasa 2019, 61(6):629-634 | DOI: 10.33678/cor.2019.040

Third degree atrioventricular block as a rare complication of Graves' thyrotoxicosis

Michal Širanec, Sudheera Magage, Martin Válek, Josef Marek, Jan Šimek, Jan Bělohlávek, Miroslav Pšenička, Aleš Linhart
2nd Department of Internal Medicine - Cardiology and Angiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague

Complete atrioventricular (AV) block is a rare but life-threatening complication of thyrotoxicosis. In the literature, only a few cases with uncertain causal link to hyperthyroid status have been described so far. Because of the lack of data, there is no clear consensus on the reversibility of AV conduction abnormality and hence on the need for permanent pacemaker implantation. In the case report, we describe a case of a 35-year-old woman with newly diagnosed Graves' thyrotoxicosis complicated by syncope due to complete AV block. Upon admission to hospital, a spontaneous recovery of the AV conduction with 1 : 1 ratio occurred, resulting in significant sinus tachycardia with a heart rate of 150 bpm, which manifested by chest pain and pre-collapse state and led to the development of heart failure due to hyperkinetic circulation. Further complication was an asystole caused by a recurrence of complete AV block without occurrence of escape rhythm, with the need of a 2-minute cardiopulmonary resuscitation and emergency temporary transvenous pacing. After 48 hours of thyrostatic and corticosteroid treatment, the heart rhythm stabilized, with a tendency to sinus tachycardia. The further course was uncomplicated, including a good beta-blocker tolerance. A comprehensive examination (including cardiac magnetic resonance) did not show any other cause explain- ing the complete AV block. The patient refused permanent pacemaker implantation which was considered. During the next 3-month follow-up, a recurrence of AV block did not occur.

Keywords: Asystole, Graves' disease, Sinus tachycardia, Third degree atrioventricular block, Thyrotoxicosis

Accepted: February 2, 2019; Published: December 15, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Širanec M, Magage S, Válek M, Marek J, Šimek J, Bělohlávek J, et al.. Third degree atrioventricular block as a rare complication of Graves' thyrotoxicosis. Cor Vasa. 2019;61(6):629-634. doi: 10.33678/cor.2019.040.
Download citation

References

  1. Kahaly GJ, Bartalena L, Hegedus L, et al. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Eur Thyroid J 2018;7:167-186. Go to original source... Go to PubMed...
  2. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016;26. Ahead of print. http://doi.org/10.1089/thy.2016.0229 Go to original source... Go to PubMed...
  3. Smith TJ, Hegedus L. Graves' Disease. N Engl J Med 2016;375:1552-1565. Go to original source... Go to PubMed...
  4. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509. Go to original source... Go to PubMed...
  5. Bayliss RI, Edwards OM. Urinary excretion of free catecholamines in Graves' disease. J Endocrinol 1971;49:167-173. Go to original source... Go to PubMed...
  6. Carvalho-Bianco SD, Kim BW, Zhang JX, et al. Chronic cardiac--specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness. Mol Endocrinol 2004;18:1840-1849. Go to original source... Go to PubMed...
  7. Smolenski RT, Yacoub MH, Seymour AM. Hyperthyroidism increases adenosine transport and metabolism in the rat heart. Mol Cell Biochem 1995;143:143-149. Go to original source... Go to PubMed...
  8. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990;88:626-630. Go to original source... Go to PubMed...
  9. Resnekov L, Falicov RE. Thyrotoxicosis and lactate-producing angina pectoris with normal coronary arteries. Br Heart J 1977;39:1051-1057. Go to original source... Go to PubMed...
  10. Choi YH, Chung JH, Bae SW, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis 2005;16:135-139. Go to original source... Go to PubMed...
  11. Reynolds JL, Woody HB. Thyrotoxic mitral regurgitation: a probable form of intrinsic papillary muscle dysfunction. Am J Dis Child 1971;122:544-548. Go to original source... Go to PubMed...
  12. Cavros NG, Old WD, Castro FD, Estep HL. Case report: reversible mitral regurgitation and congestive heart failure complicating thyrotoxicosis. Am J Med Sci 1996;311:142-144. Go to original source...
  13. Auer J, Scheibner P, Mische T, et al. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001;142:838-842. Go to original source... Go to PubMed...
  14. Valcavi R, Menozzi C, Roti E, et al. Sinus node function in hyperthyroid patients. J Clin Endocrinol Metab 1992;75:239-242. Go to original source...
  15. Freedberg AS, Papp JG, Williams EM. The effect of altered thyroid state on atrial intracellular potentials. J Physiol 1970;207:357-369. Go to original source... Go to PubMed...
  16. Fatourechi V, Edwards WD. Graves' disease and low-output cardiac dysfunction: implications for autoimmune disease in endomyocardial biopsy tissue from eleven patients. Thyroid 2000;10:601-605. Go to original source... Go to PubMed...
  17. Kramer MR, Shilo S, Hershko C. Atrioventricular and sinoatrial block in thyrotoxic crisis. Br Heart J 1985;54:600-602. Go to original source... Go to PubMed...
  18. Stern MP, Jacobs RL, Duncan GW Complete heart block complicating hyperthyroidism. JAMA 1970;212:2117-2119. Go to original source...
  19. Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 2017;14:39-55. Go to original source... Go to PubMed...
  20. Ortmann C, Pfeiffer H, Du Chesne A, Brinkmann B. Inflammation of the cardiac conduction system in a case of hyperthyroidism. Int J Legal Med 1999;112:271-274. Go to original source... Go to PubMed...
  21. Ozcan KS, Osmonov D, Erdinler I, et al. Atrioventricular block in patients with thyroid dysfunction: prognosis after treatment with hormone supplementation or antithyroid medication. J Cardiol 2012;60:327-332. Go to original source... Go to PubMed...
  22. Yusoff K, Khalid BA. Conduction abnormalities in thyrotoxicosis - a report of three cases. Ann Acad Med Singapore 1993;22:609-612.
  23. Barra SNC, Providencia R, Paiva L, et al. A review on advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 2012;35:1395-1405. Go to original source... Go to PubMed...
  24. Táborský M, Kautzner J. Summary of the 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Prepared by the Czech Society of Cardiology. Cor Vasa 2014;56:e57-e74. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.